1. 2377. Outcomes in Patients With History of Cardiac or Vascular Disease (CV) During Treatment of Acute Bacterial Skin And Skin Structure Infection (ABSSSI) With Delafloxacin (DLX) vs. Vancomycin/Aztreonam (VAN/AZ). (26th November 2018) Authors: Oguchi, Godson; Beasley, Richard; Lawrence, Laura; Tseng, Carol; Cammarata, Sue K Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S708 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III study. Issue 4 (10th March 2015) Authors: Nelson, David R.; Cooper, James N.; Lalezari, Jacob P.; Lawitz, Eric; Pockros, Paul J.; Gitlin, Norman; Freilich, Bradley F.; Younes, Ziad H.; Harlan, William; Ghalib, Reem; Oguchi, Godson; Thuluvath, Paul J.; Ortiz‐Lasanta, Grisell; Rabinovitz, Mordechai; Bernstein, David; Bennett, Michael; Hawk... Journal: Hepatology Issue: Volume 61:Issue 4(2015:Apr.) Page Start: 1127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from boosted protease inhibitor-based regimens in virologically suppressed adults with HIV-1: 48 week results of a randomised, open-label, multicentre, phase 3, non-inferiority trial. Issue 7 (July 2018) Authors: Daar, Eric S; DeJesus, Edwin; Ruane, Peter; Crofoot, Gordon; Oguchi, Godson; Creticos, Catherine; Rockstroh, Jürgen K; Molina, Jean-Michel; Koenig, Ellen; Liu, Ya-Pei; Custodio, Joseph; Andreatta, Kristen; Graham, Hiba; Cheng, Andrew; Martin, Hal; Quirk, Erin Journal: Lancet Issue: Volume 5:Issue 7(2018) Page Start: e347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. LB1. Remdesivir for the Treatment of High-Risk Non-Hospitalized Individuals With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial. (4th December 2021) Authors: Hill, Joshua A; Paredes, Roger; Vaca, Carlos; Mera, Jorge; Webb, Brandon J; Perez, Gilberto; Oguchi, Godson; Ryan, Pablo; Gerstoft, Jan; Brown, Michael; Schiffer, Joshua; Brown, Samuel; Katz, Morgan; Ginde, Adit A; Camus, Gregory; Porter, Danielle P; Hyland, Robert H; Chen, Shuguang; Juneja, Kavi... Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S806 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase 3 Randomized, Controlled Trial of Switching to Fixed-dose Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) from Boosted Protease Inhibitor-based Regimens in Virologically Suppressed Adults: Week 48 Results. (4th October 2017) Authors: Daar, Eric; DeJesus, Edwin; Ruane, Peter; Crofoot, Gordon; Oguchi, Godson; Creticos, Catherine; Rockstroh, Jurgen K; Molina, Jean-Michel; Koenig, Ellen; Liu, Ya-Pei; Andreatta, Kristen; Graham, Hiba; Cheng, Andrew; Martin, Hal; Quirk, Erin Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗